• Editorial Staff
  •  
  • Clinical Editor:
  • Terry Treadwell, MD, FACS
  •  
  • Managing Editor:
  • Barbara Drosey
  •  
  • Associate Editor:
  • Kelsey Moroz
  •  
  • Web Editor:
  • Samantha Alleman
  • Editorial Correspondence:
  •  
  • Barbara Drosey, Managing Editor, WOUNDS
  •  
  • HMP Communications, 83 General Warren Blvd
  • Suite 100, Malvern, PA 19355
  •  
  • Telephone: (800) 237-7285 or
  • (610) 560-0500, ext. 258
  • Fax: (610) 560-0501.
  • E-mail: bdrosey@hmpcommunications.com
August, 2002 | Volume 14 - Issue 8

Wound Treatments vs. Wound Healing; Are All Pressure Ulcers Avoidable?

Home Care Nurses’ Ratings of Wound Care Appropriateness of Wound Treatments and Wound Healing
Peiper B, Templin T, Dobal M, Jacox A. Home care nurses’ ratings of appropriateness of wound treatments and wound healing. JWOCN 2002;29:20–28.

Rationale: Nurses play a key role in management of 31 to 36 percent of patients in home care who have wounds. Use of appropriate dressings improves healing and patient satisfaction, while reducing infections, pain, and the costs of care. Home care agencies often lack standardized protocols of care or consistent patient or caregiv...

Report on the 2002 Annual Meeting of The Wound Healing Society

The Wound Healing Society (WHS) held its annual meeting in Baltimore, Maryland, May 28 through June 1, 2002. This year’s meeting was a joint conference with the European Tissue Repair Society (ETRS) with scientific and educational programs designed to “Discover Emerging Research Critical to the Future of Wound Care.” The conference venue at the Renaissance Harborplace Hotel near Baltimore’s Inner Harbor provided a comfortable, centralized environment conducive to both formal and informal interactions among the more than 475 attendees and 19 exhibiting corporations.

The overall prog...

Primary Localized Cutaneous Amyloidosis, Macular Type

Department Editor
Tania Phillips, MD, FRCPC

Overall Learning Objectives: The physician or podiatrist participant will develop a rational approach to the evaluation and treatment of a variety of uncommon wounds and will have an increased awareness of the differential diagnosis of cutaneous wounds and the systemic diseases associated with these wounds.

Submissions: To submit a case for consideration in Diagnostic Dilemmas, e-mail or write to: Executive Editor, WOUNDS, 83 General Warren Blvd., Suite 100, Malvern, PA 19355, eklumpp@hmpcommunications.com

Completio...

September

Medline Launches SilvaSorb™ Line of Antimicrobial Silver Wound Dressings for Chronic Wounds

Medline Industries, Inc., is launching the first line of antimicrobial silver wound dressings that combines sustained release antimicrobial silver with highly effective moisture management materials for helping heal chronic wounds and reducing infection. Called SilvaSorb™, this new line is a major addition to Medline’s family of controlled-release silver wound care products, including Arglaes®.

SilvaSorb is a sterile, single-use wound dressing for use in moist wound management. It combines...

September

New Risk Management Program Available to Long-Term Care Facilities

Pathways, a new risk management program available to long-term care organizations, helps identify risks associated with wound care and avoid potentially costly fines and litigation. Augustine Medical, the makers of Warm-Up wound therapy, developed the Pathways program to focus on 1) developing skin integrity care plans for individual patients and 2) educating care providers to identify, assess, treat, and promote healing of wounds.

Pathways helps clinicians appropriately assess wounds, initiate treatment, and easily docu...

The Effects of P-selectin Receptor Antagonist rPSGL-Ig on Wound Healing in a Rodent Model

Introduction

P-selectin glycoprotein ligand-Ig (rPSGL-Ig) is a novel P-selectin glycoprotein ligand-Ig receptor antagonist that decreases leukocyte rolling and tethering onto stimulated endothelial cells and platelets, thus decreasing the inflammatory response.1 Recent research in venous thrombosis using rPSGL-Ig showed that pretreatment, prior to thrombus induction, significantly inhibited vein wall inflammation. However, the monocyte population, which is necessary for the normal progression of wound healing, was not significantly altered.2 As rPSGL-Ig will likely be used in ...

The Use of New Antimicrobial Gauze Dressings: Effects on the Rate of Epithelialization of Partial-Thickness Wounds

Introduction

For many years, gauze has been used for a wide variety of situations: 1) primary and secondary dressing in conjunction with compression therapy, 2) debridement, 3) secondary dressing for grafts, 4) abdominal incisions, 5) packing of wounds, etc. One of the benefits of gauze is its excellent absorbent property. However, gauze has never been viewed as a barrier to infection. The idea of an antimicrobial gauze dressing that could prevent the entrance of wound pathogens is very attractive. The use of topical antimicrobials in wounds has been controversial, and various investigator...

Alternate Applications of Living Skin Equivalent

Introduction

Living skin equivalent (LSE)*, or tissue-engineered skin, is a bilaminar structure of epithelium cultured upon a dermal equivalent. Clinically, it has characteristics that closely resemble a skin graft. As such, it is used in the capacity of a prefabricated skin graft. LSE is currently approved by the FDA for chronic wounds, specifically certain diabetic foot ulcers (DFU) and venous stasis ulcers (VSU).1–3 As clinical experience broadens with LSE, physicians across the country are reporting its use in the treatment of other, “off-label” wounds beyond those approved...

Debridement: Rationale and Therapeutic Options

Back to top
iuwerksdfgh